Not Yet RecruitingNot Applicable

A Prospective Study of Cardiovascular Risk of Patients Admitted for Acute Exacerbation of COPD

150 participantsStarted 2026-01-15

Plain-language summary

This is a prospective study to assess the burden of existing or hidden cardiovascular (CV) and renal disease in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in a Hong Kong public hospital setting. By implementing a chronic obstructive pulmonary disease (COPD) discharge care bundle with integrated CV/renal screening, the study aims to quantify undiscovered disease prevalence, evaluate risk factors for future exacerbations, and compare re-admission rates against historical controls, ultimately informing integrated cardiopulmonary management strategies.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥40 years * Patients hospitalized due to COPD exacerbation. * Patients diagnosed with COPD, a confirmed COPD diagnosis with a specific FEV1/FVC ratio (\<0.70) * Able to provide informed consent Exclusion Criteria: * Pregnant subjects * Inability to give informed consent * Cancer patient who are on active chemotherapy or on palliative care

What they're measuring

Percentage of patients observed to have different high-risk factors for future COPD exacerbation

Timeframe: 12 months

Trial details

NCT IDNCT07344285

SponsorChinese University of Hong Kong

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2029-01-16

Contact for this trial

Fanny WS Ko, MD

85235053133 fannyko@cuhk.edu.hk

View on ClinicalTrials.gov More COPD trials